Cargando…

From sea to shining IV: the current state of OPAT in the United States

First described in the United States, outpatient parenteral antibiotic therapy (OPAT) has become an indispensable part of treating serious infections. The proportion of infectious disease (ID) physicians utilizing a formal OPAT program has increased in recent years, but remains a minority. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larnard, Jeffrey, Swords, Kyleen, Taupin, Dan, Padival, Simi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Outpatient Parenteral Antimicrobial Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285263/ https://www.ncbi.nlm.nih.gov/pubmed/37363442 http://dx.doi.org/10.1177/20499361231181486

Ejemplares similares

Facilitating OPAT in rural areas
por: Mehta, Meera, et al.
Publicado: (2023)

Exploring the advancements of Australian OPAT
por: Lai, Tony, et al.
Publicado: (2023)

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion
por: Van Abel, Amy L., et al.
Publicado: (2023)

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs
por: Douglass, Alyse H., et al.
Publicado: (2023)

Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
por: Billmeyer, Kaylyn N., et al.
Publicado: (2023)

What is the role of the clinical microbiology laboratory in the care of diagnostically challenging OPAT patients? Illustrative cases and literature review
por: Nori, Priya, et al.
Publicado: (2023)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Identifying the potential impact of a multidisciplinary outpatient antimicrobial therapy program in an area of high social vulnerability
por: Tan, Karen K., et al.
Publicado: (2023)

Retrospective analysis of the management of pelvic decubitus ulcers and their outcomes
por: Damioli, Laura, et al.
Publicado: (2023)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
por: Bradley, Abby C., et al.
Publicado: (2023)

Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

Taking the route less traveled: on the way to COpAT
por: Pertzborn, Margaret, et al.
Publicado: (2023)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

Benefits of quitting smoking on work productivity and activity impairment in the United States, the European Union and China
por: Baker, Christine L., et al.
Publicado: (2017)

1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018)

General Principles of Antimicrobial Therapy
por: Leekha, Surbhi, et al.
Publicado: (2011)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States
por: Rivera, Christina G, et al.
Publicado: (2021)

Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program
por: Britt, Rachel S., et al.
Publicado: (2023)

Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China
por: Liu, Congcong, et al.
Publicado: (2022)

Nutrición enteral y parenteral
Publicado: (1993)

Endonutrición : estado del arte en nutrición clínica /
Publicado: (2007)

Endonutrición : apoyo nutricio /
Publicado: (2013)

Up to date on the use of triptans for child and adolescent migraine: state of the art
por: Calderoni, Dario, et al.
Publicado: (2001)

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
por: Guo, Shibang, et al.
Publicado: (2023)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Micafungin in Premature and Non-premature Infants: A Systematic Review of 9 Clinical Trials
por: Manzoni, Paolo, et al.
Publicado: (2014)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
por: Domachowske, Joseph B., et al.
Publicado: (2018)

Antibiotic Resistance Among Pediatric-Sourced Ocular Pathogens: 8-Year Findings From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study
por: Alter, Sherman J., et al.
Publicado: (2019)

Exploiting Homoplasy in Genome-Wide Association Studies to Enhance Identification of Antibiotic-Resistance Mutations in Bacterial Genomes
por: Lai, Yi-Pin, et al.
Publicado: (2020)

A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa
por: Ocampo-Ibáñez, Iván Darío, et al.
Publicado: (2020)

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)
por: Baker, Jeffrey, et al.
Publicado: (2020)

Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
por: Yokoyama, Takato, et al.
Publicado: (2020)

Draft Genome Sequence of Ciprofloxacin and Ceftriaxone Resistant Campylobacter jejuni MM26-781 Assigned to Novel ST Isolated From Common Pigeon in Lithuania
por: Aksomaitiene, Jurgita, et al.
Publicado: (2019)

Molecular Docking of Broad-Spectrum Antibodies on Hemagglutinins of Influenza A Virus
por: Le, Khanh PB, et al.
Publicado: (2019)

Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates
por: Yu, Collin Z., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_81cj9im7b0j8gp8br8t5j9fsv8